Atossa Genetics Basic EPS 2012-2025 | ATOS
Atossa Genetics basic eps from 2012 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Atossa Genetics Annual Basic EPS | |
|---|---|
| 2024 | $-0.20 |
| 2023 | $-0.24 |
| 2022 | $-0.21 |
| 2021 | $-0.18 |
| 2020 | $-1.97 |
| 2019 | $-2.03 |
| 2018 | $-5.50 |
| 2017 | $-10.97 |
| 2016 | $-25.93 |
| 2015 | $-99.76 |
| 2014 | $-109.79 |
| 2013 | $-125.99 |
| 2012 | $-73.79 |
| 2011 | $-68.39 |
| Atossa Genetics Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $-0.07 |
| 2025-03-31 | $-0.05 |
| 2024-12-31 | $-0.04 |
| 2024-09-30 | $-0.06 |
| 2024-06-30 | $-0.05 |
| 2024-03-31 | $-0.05 |
| 2023-12-31 | $-0.06 |
| 2023-09-30 | $-0.05 |
| 2023-06-30 | $-0.08 |
| 2023-03-31 | $-0.05 |
| 2022-12-31 | $-0.06 |
| 2022-09-30 | $-0.06 |
| 2022-06-30 | $-0.05 |
| 2022-03-31 | $-0.04 |
| 2021-12-31 | $-0.04 |
| 2021-09-30 | $-0.04 |
| 2021-06-30 | $-0.06 |
| 2021-03-31 | $-0.04 |
| 2020-12-31 | $-0.88 |
| 2020-09-30 | $-0.34 |
| 2020-06-30 | $-0.43 |
| 2020-03-31 | $-0.32 |
| 2019-12-31 | $-0.25 |
| 2019-09-30 | $-0.36 |
| 2019-06-30 | $-0.80 |
| 2019-03-31 | $-0.62 |
| 2018-12-31 | $8.70 |
| 2018-09-30 | $-0.64 |
| 2018-06-30 | $-5.08 |
| 2018-03-31 | $-8.48 |
| 2017-12-31 | $4.26 |
| 2017-09-30 | $-2.11 |
| 2017-06-30 | $-7.72 |
| 2017-03-31 | $-5.40 |
| 2016-12-31 | $-6.96 |
| 2016-09-30 | $0.84 |
| 2016-06-30 | $-8.04 |
| 2016-03-31 | $-11.77 |
| 2015-12-31 | $-28.47 |
| 2015-09-30 | $-28.09 |
| 2015-06-30 | $-19.80 |
| 2015-03-31 | $-23.40 |
| 2014-12-31 | $-45.00 |
| 2014-09-30 | $-23.40 |
| 2014-06-30 | $-23.40 |
| 2014-03-31 | $-18.00 |
| 2013-12-31 | $-30.60 |
| 2013-09-30 | $-39.60 |
| 2013-06-30 | $-30.60 |
| 2013-03-31 | $-25.20 |
| 2012-12-31 | $-21.60 |
| 2012-09-30 | $-18.00 |
| 2012-06-30 | $-18.00 |
| 2012-03-31 | $-16.20 |
| 2011-12-31 | |
| 2011-09-30 | $-19.80 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.100B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.656B | 22.34 |
| Intuitive Surgical (ISRG) | United States | $172.162B | 71.36 |
| IDEXX Laboratories (IDXX) | United States | $52.070B | 54.19 |
| Edwards Lifesciences (EW) | United States | $45.946B | 30.45 |
| Alcon (ALC) | Switzerland | $43.262B | 29.24 |
| IQVIA Holdings (IQV) | United States | $32.485B | 18.36 |
| DexCom (DXCM) | United States | $31.745B | 47.62 |
| Mettler-Toledo (MTD) | United States | $27.033B | 32.09 |
| STERIS (STE) | Ireland | $24.185B | 25.74 |
| Waters (WAT) | United States | $17.354B | 23.84 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.707B | 0.00 |
| Hologic (HOLX) | United States | $15.082B | 16.34 |
| Penumbra (PEN) | United States | $9.868B | 72.09 |
| Sysmex ADR (SSMXY) | Japan | $8.529B | 27.10 |
| Masimo (MASI) | United States | $8.359B | 28.13 |
| Globus Medical (GMED) | United States | $8.200B | 18.87 |
| Teleflex (TFX) | United States | $5.333B | 8.61 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| TransMedics (TMDX) | United States | $4.348B | 66.09 |
| Integer Holdings (ITGR) | United States | $3.741B | 18.67 |
| LivaNova (LIVN) | United Kingdom | $2.933B | 16.79 |
| Veracyte (VCYT) | United States | $2.377B | 32.85 |
| Alphatec Holdings (ATEC) | United States | $2.323B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.314B | 0.00 |
| Artivion (AORT) | United States | $2.020B | 101.93 |
| Nihon Kohden (NHNKY) | Japan | $1.911B | 22.82 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Integra LifeSciences Holdings (IART) | United States | $1.106B | 6.33 |
| OPKO Health (OPK) | United States | $1.087B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $0.895B | 43.44 |
| Beta Bionics (BBNX) | United States | $0.741B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.731B | 0.00 |
| AxoGen (AXGN) | United States | $0.687B | 0.00 |
| SiBone (SIBN) | United States | $0.667B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.558B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.520B | 9.18 |
| Semler Scientific (SMLR) | United States | $0.501B | 4.02 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.435B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.379B | 9.63 |
| Delcath Systems (DCTH) | United States | $0.362B | 86.33 |
| AngioDynamics (ANGO) | United States | $0.356B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.328B | 0.00 |
| NeuroPace (NPCE) | United States | $0.283B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.278B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.277B | 19.09 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.227B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.190B | 0.00 |
| CVRx (CVRX) | United States | $0.184B | 0.00 |
| Accuray (ARAY) | United States | $0.158B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.156B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.115B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.095B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.081B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.18 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.27 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |